Chronic Lymphocytic Leukemia CLL Mutations Detection Comprehensive Panel Test sale cost 1400 AED
BCR-ABL Quantitative MRD Monitor Test sale cost 1400 AED BCR-ABL Quantitative MRD Monitor Test Cost 1,560 د.إ Original price was: 1,560 د.إ.1,400 د.إCurrent price is: 1,400 د.إ.
Neuroblastoma Profile 24 Hour Urine Test sale cost 1400 AED Neuroblastoma Profile 24 Hour Urine Test Cost 1,560 د.إ Original price was: 1,560 د.إ.1,400 د.إCurrent price is: 1,400 د.إ.
Sale!

Chronic Lymphocytic Leukemia CLL Mutations Detection Comprehensive Panel Test Cost

Original price was: 1,560 د.إ.Current price is: 1,400 د.إ.

-10%

The “Chronic Lymphocytic Leukemia (CLL) Mutations Detection Comprehensive Panel Test” is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify specific genetic mutations associated with CLL. This test plays a crucial role in the personalized management and treatment of patients with CLL, as it helps in understanding the genetic underpinnings of the disease in individual patients. By analyzing a comprehensive panel of genes known to be mutated in CLL, the test provides insights into prognosis, disease progression, and potential response to various treatments. With a cost of 1400 AED, the test is a valuable resource for patients and healthcare providers aiming for a targeted approach in battling CLL, enabling more effective and tailored therapeutic strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION COMPREHENSIVE PANEL Test

At DNA Labs UAE, we offer the CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) MUTATIONS DETECTION COMPREHENSIVE PANEL Test. This diagnostic test is designed to identify specific genetic mutations in patients with CLL, a type of cancer that affects the lymphocytes, a type of white blood cell.

Test Components:

  • SF3B1 K700E mutation
  • MYD88 L265P mutation
  • NOTCH1 p.2514 fs mutation
  • PTEN loss at 10q23.31
  • 11q deletion
  • Trisomy 12
  • 13q14 deletion
  • 14q deletion
  • 17p deletion
  • Trisomy 19
  • Chromosome 2p gain
  • 6q deletion
  • 8p loss & 8q amplification
  • 9p21 loss

Price: 1400.0 AED

Sample Condition:

4 mL (2 mL min.) whole blood from 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery:

SampleMon by 11 am; ReportSat

Method:

PCR – MLPA

Test Type:

Cancer

Doctor:

Oncologist

Test Department:

MOLECULAR DIAGNOSTICS

Pre Test Information:

Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details:

The Chronic Lymphocytic Leukemia (CLL) Mutations Detection Comprehensive Panel Test is a diagnostic test used to identify specific genetic mutations in patients with CLL. This panel test analyzes multiple genes known to be associated with CLL, including TP53, NOTCH1, SF3B1, ATM, and others. These genes are frequently mutated in CLL and can provide important information about the prognosis and treatment options for the patient.

The test is typically performed on a blood or bone marrow sample from the patient. The DNA from the sample is extracted and sequenced to identify any mutations or changes in the targeted genes. The results of the test can help guide treatment decisions, as certain mutations may indicate a higher risk of disease progression or resistance to certain therapies.

Overall, the CLL Mutations Detection Comprehensive Panel Test is a valuable tool in the management of CLL, providing important genetic information that can help personalize treatment plans for patients.

Test Name CHRONIC LYMPHOCYTIC LEUKEMIA CLL MUTATIONS DETECTION COMPREHENSIVE PANEL Test
Components *SF3B1 K700E mutation*MYD88 L265P mutation*NOTCH1 p.2514 *fs mutation *PTEN loss at 10q23.31*11q deletion *Trisomy 12 *13q14 deletion*14q deletion*17p deletion*Trisomy 19 *Chromosome 2p gain*6q deletion*8p loss & 8q amplification*9p21 loss
Price 1400.0 AED
Sample Condition 4 mL (2 mL min.) whole blood from 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery SampleMon by 11 am;ReportSat
Method PCR – MLPA
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

The Chronic Lymphocytic Leukemia (CLL) Mutations Detection Comprehensive Panel Test is a diagnostic test used to identify specific genetic mutations in patients with CLL. CLL is a type of cancer that affects the lymphocytes, a type of white blood cell.

This panel test analyzes multiple genes known to be associated with CLL, including TP53, NOTCH1, SF3B1, ATM, and others. These genes are frequently mutated in CLL and can provide important information about the prognosis and treatment options for the patient.

The test is typically performed on a blood or bone marrow sample from the patient. The DNA from the sample is extracted and sequenced to identify any mutations or changes in the targeted genes. The results of the test can help guide treatment decisions, as certain mutations may indicate a higher risk of disease progression or resistance to certain therapies.

Overall, the CLL Mutations Detection Comprehensive Panel Test is a valuable tool in the management of CLL, providing important genetic information that can help personalize treatment plans for patients.

SKU: TEST-5394 Category:

Related products